Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5867 Articles

Chris Lange | Aug 19, 2020 at 9:55 AM EDT

What This FDA Response Means for BioMarin’s Gene Therapy for Hemophilia

BioMarin Pharmaceutical stock was crushed on Wednesday after an FDA response regarding its valoctocogene roxaparvovec gene therapy for severe hemophilia…

Chris Lange | Aug 18, 2020 at 10:40 AM EDT

Vanda Pharma’s Big Step Forward in COVID-19 Pneumonia

Vanda Pharmaceuticals took another big step forward in the fight against COVID-19 on Tuesday morning.

Lee Jackson | Aug 18, 2020 at 7:04 AM EDT

BofA Securities Adds Medical Technology Giant to the US 1 List

With the market showing the potential for some sizable rotation, the research team at BofA Securities has added Medtronic to…

Chris Lange | Aug 17, 2020 at 12:12 PM EDT

XBiotech Has Identified COVID-19 Antibodies to Be Used as Therapy

XBiotech shares made a handy gain on Monday after the company said that it has identified True Human antibodies that…

Chris Lange | Aug 17, 2020 at 10:57 AM EDT

Unity Bio Stock Is Literally Kneecapped

Unity Biotechnology stock was absolutely crushed on Monday after the company announced results from its midstage study in patients with…

Chris Lange | Aug 17, 2020 at 10:28 AM EDT

What Sanofi Is Adding to Its Portfolio With This New Acquisition

Principia Biopharma shares jumped to start out the week after it was announced that it would be acquired by Sanofi.

Lee Jackson | Aug 15, 2020 at 6:35 AM EDT

5 Red-Hot Biotech and Medtech Stocks Under $10 With Massive Upside Potential

These are five biotech and medtech stocks for very aggressive accounts that look to get shares count leverage on companies…

Chris Lange | Aug 14, 2020 at 1:38 PM EDT

CureVac Enters the Market With a Bang

CureVac stock exploded into the market, more than double its original pricing. Since then, it is up more or less…

Chris Lange | Aug 14, 2020 at 11:27 AM EDT

Hydroxychloroqine Could Be Back in Play With Recent Taiwan FDA Filing

Taiwan Liposome Co. Ltd (NASDAQ: TLC) shares shot higher on Friday after the company announced it was making a regulatory…

Douglas A. McIntyre | Aug 14, 2020 at 6:23 AM EDT

As COVID-19 Spreads Across America, New York Still Has Most Deaths By Far

New York State may rank fourth in COVID-19 confirmed case count, but its death toll is well over twice that…

Douglas A. McIntyre | Aug 13, 2020 at 7:01 AM EDT

Over 500,000 US COVID-19 Deaths Forecast This Year

There are several academic models of how many Americans will die of COVID-19 this year. One puts the number at…

Chris Lange | Aug 12, 2020 at 11:28 AM EDT

Moderna’s New Deal: Is This a Case of ‘Sell the News’?

When Moderna announced a new deal with the U.S. government for its COVID-19 vaccine, it appeared be a case of…

Chris Lange | Aug 12, 2020 at 11:05 AM EDT

How Is Royalty Pharma Poised After Earnings?

Royalty Pharma reported quarterly results on Wednesday morning that were boosted by Imbruvica and the addition of new royalties.

Chris Lange | Aug 12, 2020 at 8:25 AM EDT

Short Sellers Shy Away From Big Biotech

The July 31 short interest data has been compared with the previous report, and short interest in most of these…

Chris Lange | Aug 11, 2020 at 10:43 AM EDT

Eyenovia Sees the Bigger Picture With New Licensing Deal

Eyenovia shares soared on Tuesday after the company announced an exclusive license agreement with Artic Vision.

1 … 44 45 46 47 48 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

What This FDA Response Means for BioMarin’s Gene Therapy for Hemophilia

Vanda Pharma’s Big Step Forward in COVID-19 Pneumonia

BofA Securities Adds Medical Technology Giant to the US 1 List

XBiotech Has Identified COVID-19 Antibodies to Be Used as Therapy

Unity Bio Stock Is Literally Kneecapped

What Sanofi Is Adding to Its Portfolio With This New Acquisition

5 Red-Hot Biotech and Medtech Stocks Under $10 With Massive Upside Potential

CureVac Enters the Market With a Bang

Hydroxychloroqine Could Be Back in Play With Recent Taiwan FDA Filing

As COVID-19 Spreads Across America, New York Still Has Most Deaths By Far

Over 500,000 US COVID-19 Deaths Forecast This Year

Moderna’s New Deal: Is This a Case of ‘Sell the News’?

How Is Royalty Pharma Poised After Earnings?

Short Sellers Shy Away From Big Biotech

Eyenovia Sees the Bigger Picture With New Licensing Deal

Nvidia, Micron or Broadcom: What Would Raymond Dalio Do?

VGT Puts 39 Cents of Every Dollar Into Just 3 Stocks. The Pairing That Fixes It Without Selling

IRMAA Surprise: How Your 401(k) Distribution Today Triggers Medicare Surcharges Two Years Later

IRMAA Surprise: How Your 401(k) Distribution Today Triggers Medicare Surcharges Two Years Later

He Needs $30,000 for a Roof and Furnace at 69. A New Maine Law Could Help Him Borrow Without Making More of His Social Security Taxable.

Nvidia, Micron or Broadcom: What Would Raymond Dalio Do?

VGT Puts 39 Cents of Every Dollar Into Just 3 Stocks. The Pairing That Fixes It Without Selling

Health and Healthcare Articles

All Health and Healthcare Articles

What This FDA Response Means for BioMarin’s Gene Therapy for Hemophilia

Vanda Pharma’s Big Step Forward in COVID-19 Pneumonia

BofA Securities Adds Medical Technology Giant to the US 1 List

XBiotech Has Identified COVID-19 Antibodies to Be Used as Therapy

Unity Bio Stock Is Literally Kneecapped

What Sanofi Is Adding to Its Portfolio With This New Acquisition

5 Red-Hot Biotech and Medtech Stocks Under $10 With Massive Upside Potential

CureVac Enters the Market With a Bang

Hydroxychloroqine Could Be Back in Play With Recent Taiwan FDA Filing

As COVID-19 Spreads Across America, New York Still Has Most Deaths By Far

Over 500,000 US COVID-19 Deaths Forecast This Year

Moderna’s New Deal: Is This a Case of ‘Sell the News’?

How Is Royalty Pharma Poised After Earnings?

Short Sellers Shy Away From Big Biotech

Eyenovia Sees the Bigger Picture With New Licensing Deal

Nvidia, Micron or Broadcom: What Would Raymond Dalio Do?

VGT Puts 39 Cents of Every Dollar Into Just 3 Stocks. The Pairing That Fixes It Without Selling

IRMAA Surprise: How Your 401(k) Distribution Today Triggers Medicare Surcharges Two Years Later

Featured Reads

IRMAA Surprise: How Your 401(k) Distribution Today Triggers Medicare Surcharges Two Years Later

He Needs $30,000 for a Roof and Furnace at 69. A New Maine Law Could Help Him Borrow Without Making More of His Social Security Taxable.